Abnormalities in lung surfactant in horses clinically affected with recurrent airway obstruction (RAO)

Journal of Veterinary Internal Medicine

Volumn 22, Issue 6, 2008, Pages 1452-1455

  Christmann, Undine ^a,c   Welles, E G ^a   Waldridge, B M ^a   Schumacher, J ^a   Grier, B L ^b   Hite, R D ^b  

^a AUBURN UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

Heaves; Horse; Phospholipid; Surface tension

Indexed keywords

SURFACTANT ASSOCIATED PROTEIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; CHEMISTRY; CHRONIC OBSTRUCTIVE LUNG DISEASE; HORSE; HORSE DISEASE; LUNG LAVAGE; METABOLISM;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; HORSE DISEASES; HORSES; LUNG DISEASES, OBSTRUCTIVE; PULMONARY SURFACTANT-ASSOCIATED PROTEINS;

ANIMALIA; EQUIDAE;

EID: 57149117638     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2008.0177.x     Document Type: Article

References (13)

1. Frerking I, Gunther A, Seeger W, et al. Pulmonary surfactant: Functions, abnormalities and therapeutic options. Intensive Care Med 2001;27:1699-1717.
2. Postle AD. The role of pulmonary surfactant in the asthmatic response. Clin Exp Allergy 2000;30:1201-1204.
3. Hohlfeld JM, Ahlf K, Enhorning G, et al. Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge. Am J Respir Crit Care Med 1999;159:1803-1809.
4. Hite RD, Seeds MC, Bowton DL, et al. Surfactant phospholipid changes after antigen challenge: A role for phosphatidylglycerol in dysfunction. Am J Physiol Lung Cell Mol Physiol 2005;288:L610-L617.
5. Wright SM, Hockey PM, Enhorning G, et al. Altered airway surfactant phospholipid composition and reduced lung function in asthma. J Appl Physiol 2000;89:1283-1292.
6. Morrison KE, Slocombe RF, McKane SA, et al. Functional and compositional changes in pulmonary surfactant in response to exercise. Equine Vet J 1999;30(Suppl):62-66.
7. Hobo S, Oikawa M, Kuwano A, et al. Effect of transportation on the composition of bronchoalveolar lavage fluid obtained from horses. Am J Vet Res 1997;58:531-534.
8. Christmann U, Livesey LC, Taintor JS, et al. Lung surfactant function and composition in neonatal foals and adult horses. J Vet Intern Med 2006;20:1402-1407.
9. Ainsworth D. Recurrent airway obstruction (heaves). In: Reed SM, ed. Equine Internal Medicine, 2nd ed. St Louis, MO: Saunders; 2004:333-336.
10. Lavoie J-P. Chronic obstructive pulmonary disease. In: Robinson NE, ed. Current Therapy in Equine Medicine 4, 4th ed. Philadelphia, PA: WB Saunders; 1997:431-435.
11. Kaup FJ, Drommer W, Damsch S, et al. Ultrastructural findings in horses with chronic obstructive pulmonary disease (COPD). II: Pathomorphological changes of the terminal airways and the alveolar region. Equine Vet J 1990;22:349-355.
12. Jahn W. Veranderungen der Surfactantphospholipidzusammensetzung im Tracheobronchialsekret chronisch lungenkranker Pferde. Pferdeheilkunde 1984;1:155-158.
13. Haslam PL, Baughman RP. Report of ERS Task Force: Guidelines for measurement of acellular components and standardization of BAL. Eur Respir J 1999;14:245-248.